Rigel Pharma (RIGL) Tops Q3 EPS by 146c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $40.07 +3.49%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
CRMT, PKE, More
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q3 EPS of $1.46. Revenue for the quarter came in at $69.46 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Criteo Is Said To Attract Vista Equity-backed Takeover Offer - Bloomberg
- Dun & Bradstreet launches AI credit workflows on Databricks Marketplace
- Bioventus (BVS) 14497 contracts of July 12.50 calls
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
